Advertisement

Topics

Crizotinib Produced Robust Response in ALK-Positive Pediatric Lymphoma

05:14 EDT 23 Aug 2017 | Cancer Networks

Pediatric patients with ALK-positive anaplastic large cell lymphomas and inflammatory myofibroblastic tumors had strong responses to treatment with crizotinib.

Original Article: Crizotinib Produced Robust Response in ALK-Positive Pediatric Lymphoma

NEXT ARTICLE

More From BioPortfolio on "Crizotinib Produced Robust Response in ALK-Positive Pediatric Lymphoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...